C-Rad AB (publ)
SSE:CRAD-B.ST
46.55 (SEK) • At close February 20, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | C-Rad AB (publ) |
Symbool | CRAD-B.ST |
Munteenheid | SEK |
Prijs | 46.55 |
Beurswaarde | 1,531,685,855 |
Dividendpercentage | 0% |
52-weken bereik | 25.85 - 49 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Ms. Cecilia De Leeuw |
Website | https://www.c-rad.se |
An error occurred while fetching data.
Over C-Rad AB (publ)
C-Rad AB (publ), together with its subsidiaries, develops, manufactures, and sells systems with applications in radiation therapy for the treatment of cancer worldwide. The company operates through two segments, Positioning and Imaging. Its products include Sentinel 4D CT, a laser-based optical surface scanning system; Catalyst, a 4D surface image guided
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (SEK)
Cijfers zijn in miljoenen (SEK)